The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise
The facility has the capacity to produce one crore doses per day
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative
Goal of providing 12-month internship opportunities for qualified students
Subscribe To Our Newsletter & Stay Updated
